Disease The intractable diseases designated by MHLW, Japan

Diseases : 338 - Clinical trials : 34,520 / Drugs : 19,957 - ( DrugBank : 2,195 ) / Drug target genes : 613 - Drug target pathways : 297

1050100ALL diseases per page:

Showing 1 to 10 of 27 diseases

Filter by Reset     | 

ID	Disease name [Group]	Clinical trial Phase 1 / 2 / 3 / 4	Drug [ DrugBank ]	Target gene Target pathway	Domestic patients Med expenses recipients (FY2022)
47	Buerger disease [Card] 💬 "Thromboangiitis obliterans"	9 trials    | 0 / 3 / 1 / 0 💬	14 drugs   [ 7 drugs ]	5 genes   16 pathways	1,609 patients Age distribution💬   47. Buerger disease × Age Num 0-9 - 10-19 1 20-29 6 30-39 26 40-49 143 50-59 327 60-69 344 70-74 273 75- 489
57	Idiopathic dilated cardiomyopathy [Card] 💬	11 trials    | 3 / 6 / 1 / 3 💬	23 drugs   [ 12 drugs ]	9 genes   35 pathways	18,234 patients Age distribution💬   57. Idiopathic dilated cardiomyopathy × Age Num 0-9 1 10-19 14 20-29 247 30-39 671 40-49 2,032 50-59 3,861 60-69 4,580 70-74 2,769 75- 4,059
58	Hypertrophic cardiomyopathy [Card] 💬 "HCM", "Nonobstructive hypertrophic cardiomyopathy", "Nonobstructive HCM", "Obstructive hypertrophic cardiomyopathy", "Obstructive HCM", "OHCM", "Hypertrophic obstructive cardiomyopathy", "HOCM", "Mid-ventricular obstructive hypertrophic cardiomyopathy", "MVOHCM", "Mid-ventricular hypertrophic obstructive cardiomyopathy", "MVHOCM", "Apical hypertrophic cardiomyopathy", "APH", "Expansion phase hypertrophic cardiomyopathy"  "HCM", "Nonobstructive hypertrophic cardiomyopathy", "Nonobstructive HCM", "Obstructive hypertrophic ...	126 trials    | 21 / 55 / 43 / 14 💬	135 drugs   [ 42 drugs ]	46 genes   162 pathways	4,318 patients Age distribution💬   58. Hypertrophic cardiomyopathy × Age Num 0-9 - 10-19 3 20-29 145 30-39 163 40-49 339 50-59 689 60-69 1,006 70-74 665 75- 1,308
59	Restricted cardiomyopathy [Card] 💬 "Restrictive cardiomyopathy", "Constrictive cardiomyopathy"	-	-	-	60 patients Age distribution💬   59. Restricted cardiomyopathy × Age Num 0-9 - 10-19 2 20-29 23 30-39 10 40-49 6 50-59 6 60-69 9 70-74 - 75- 4
167	Marfan syndrome [Card] 💬	21 trials    | 15 / 6 / 12 / 4 💬	40 drugs   [ 11 drugs ]	10 genes   50 pathways	1,173 patients Age distribution💬   167. Marfan syndrome × Age Num 0-9 - 10-19 25 20-29 205 30-39 237 40-49 305 50-59 240 60-69 122 70-74 24 75- 15
179	Williams syndrome [Card] 💬	5 trials    | 0 / 0 / 0 / 1 💬	14 drugs   [ 7 drugs ]	8 genes   32 pathways	56 patients Age distribution💬   179. Williams syndrome × Age Num 0-9 - 10-19 5 20-29 37 30-39 5 40-49 6 50-59 2 60-69 1 70-74 - 75- -
188	Polysplenia syndrome [Card] 💬	-	-	-	63 patients Age distribution💬   188. Polysplenia syndrome × Age Num 0-9 1 10-19 2 20-29 42 30-39 11 40-49 1 50-59 4 60-69 1 70-74 1 75- -
189	Asplenia syndrome [Card] 💬	-	-	-	91 patients Age distribution💬   189. Asplenia syndrome × Age Num 0-9 - 10-19 3 20-29 74 30-39 12 40-49 1 50-59 1 60-69 - 70-74 - 75- -
203	22q11.2 deletion syndrome [Card] 💬	5 trials    | 2 / 1 / 1 / 0 💬	7 drugs   [ 1 drug ]	14 genes   23 pathways	73 patients Age distribution💬   203. 22q11.2 deletion syndrome × Age Num 0-9 1 10-19 7 20-29 42 30-39 9 40-49 9 50-59 5 60-69 - 70-74 - 75- -
207	Persistent truncus arteriosus [Card] 💬 "Persistent truncus arteriosus type I", "Persistent truncus arteriosus type II", "Persistent truncus arteriosus type III", "Persistent truncus arteriosus type IV"  "Persistent truncus arteriosus type I", "Persistent truncus arteriosus type II", "Persistent truncus ...	-	-	-	38 patients Age distribution💬   207. Persistent truncus arteriosus × Age Num 0-9 - 10-19 1 20-29 31 30-39 4 40-49 2 50-59 - 60-69 - 70-74 - 75- -

FirstPrevious123NextLast